Recombinant Human Noggin Protein, Fc Chimera, GMP grade

Product Code: G-GFC0578

Catalog Number Unit Size Price
G-GFC0578-25ug 25ug Online Inquiry
G-GFC0578-50 ug 50 ug Online Inquiry
G-GFC0578-1 mg 1 mg Online Inquiry

Description

Noggin, also known as NOG, SYM1, and SYNS1, is a secreted homodimeric glycoprotein. Noggin inhibits TGF-β signal transduction by binding to TGF-β family ligands and preventing them from binding to their corresponding receptors. Noggin was originally identified as a BMP-4 antagonist whose action is critical for proper formation of the head and other dorsal structures.
Noggin is essential for proper skeletal development, excess BMP activity in the Noggin null mutant results in excess cartilage and failure to initiate joint formation.
During the culture of human embryonic stem cells (hESC) or neural stem cells under certain conditions, addition of Noggin to antagonize BMP activity may allow stem cells to proliferate while maintaining their undifferentiated state, or alternatively, to differentiate into dopaminergic neurons. Noggin also appears to maintain adult stem cell populations in vivo, for example, maintaining neural stem cells within the hippocampus.

Specification

Source
Mouse myeloma cell line, NS0-derived human Noggin protein, Gln28-Cys232
Reactivity
Human
N-terminal Sequence
Amino acid sequencing was blocked, suggesting it is consistent with Gln28 as the first N-terminal amino acid. Predicted N-terminal sequence: Gln28-His-Tyr-Leu-His-Ile-Arg-Pro-Ala-Pro
Purity
>90%, by SDS-PAGE with silver staining, under reducing conditions.
Molecular Mass (Predicted)
49.6 kDa (monomer)
SDS-PAGE
58-62 kDa, reducing conditions110-130 kDa, non-reducing conditions
Accession
Q13253.1
Biological Activity
Measured by its ability to inhibit BMP-4-induced alkaline phosphatase production by ATDC5 mouse chondrogenic cells. The ED50 for this effect is 0.1-0.4 μg/mL in the presence of 30 ng/mL of Recombinant Human BMP‑4 (Catalog # 314-BP).
Endotoxin
<0.10 EU per 1 μg of the protein by the LAL method.
Application
Bioactivity
For research or further manufacturing use only. Not for use in humans.

CONTACT US

USA
Europe

ABOUT US

As a pioneer of biotechnology, Creative Bioarray has developed into a leading biotechnology company in the world. We are committed to providing our customers with innovative high-quality products and services through discovering, developing, and manufacturing.

Copyright © 2024 Creative Bioarray. All rights reserved.